February 16, 2024 Experience Amer Sports $1.2 billion credit facilities and €700 million credit facility We advised the borrowers on the financing transactions
February 14, 2024 Experience Export Development Canada $3.5 billion global bond offering The investment-grade bonds are due 2029
February 14, 2024 Experience Cigna $4.5 billion senior notes offering The senior notes are due 2029, 2031, 2034 and 2054
February 14, 2024 Experience Estée Lauder $650 million senior notes offering The investment-grade notes are due 2034
February 13, 2024 Experience Metagenomi $93.75 million IPO The shares are listed on the Nasdaq Global Market
February 12, 2024 Experience Tenaya Therapeutics $50 million stock and pre-funded warrants offering The stock is listed on the Nasdaq Global Select Market
February 12, 2024 Experience Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics We are advising Gilead Sciences on the acquisition
February 12, 2024 Experience Eli Lilly $6.5 billion notes offering The investment-grade notes are due 2027, 2029, 2034, 2054 and 2064
February 12, 2024 Experience Deutsche Bank $1 billion notes offering The fixed-to-floating-rate eligible liabilities notes are due 2028
February 9, 2024 Experience Air Products and Chemicals $2.5 billion green notes offering The investment-grade notes are due 2029, 2031 and 2034